INSIGHTS ON DRUG DEVELOPMENT
-
![GettyImages-1166567575-cell-culture-experiment-equipment-scientist]( "Cost And Scalability Key Drivers Of Expanded Gene Therapy Access")
Cost And Scalability Key Drivers Of Expanded Gene Therapy AccessGene therapies are expanding beyond rare diseases, but high costs hinder access. Discover how innovations in viral vector manufacturing could make these breakthroughs more affordable.
-
![GettyImages-2215842261-lab-scientist-looking-down-research]( "Silencing CDMO Project Noise: The Power Of Low-Drama Drug Development")
Silencing CDMO Project Noise: The Power Of Low-Drama Drug DevelopmentMove beyond reactive firefighting by prioritizing disciplined leadership and data-driven milestones. The winning model for complex programs is focused, high-maturity, low-drama execution.
-
![GettyImages-2178829362-glp-1-protein-3d-render]( "Accelerating Method Development And Manufacturing Of GLP-1 Analogs")
Accelerating Method Development And Manufacturing Of GLP-1 AnalogsExplore a streamlined LC-UV/MS workflow that empowers labs to meet rising GLP-1 drug demand with faster, more informed decisions that enhance compliance and impurity detection efficiency.
-
![GettyImages-2029622961 lab]( "Best-In-Class Nanodevelopment Capabilities")
Best-In-Class Nanodevelopment CapabilitiesA highly specialized team excels in creating unique nanoparticles for both small and large molecule APIs. Leveraging cutting-edge technology, they produce nanoformed materials as small as 10 nanometers.
-
Effect Of Column Chemistry On The Separation Of GLP-1 Peptides7/29/2026
Small changes in mobile phase, temperature, and column chemistry can affect the detection of GLP-1 peptide impurities. Learn which conditions improve resolution for challenging peptide analyses.
-
Expanding Opportunities For Inhaled Drug Delivery7/11/2025
Review the challenges and intricacies of effectively delivering drugs to the lung and the advantages of using nanoparticles and gentle particle processing techniques to enable delivery of sensitive drugs.
-
Advancing Multiomics Through Intelligent Automation10/27/2025
Modern automation tackles hidden pipetting errors and boosts reproducibility. Discover how your lab can scale confidently, reduce rework, and accelerate multiomic workflows with built-in traceability.
-
Lonza Advanced Synthesis Capabilities Update February 2026: AI Drug Development3/2/2026
Learn how our scientists accurately predict and identify the most stable cocrystal forms by leveraging advanced machine learning models, enhancing efficiency and reducing development risks.
-
Streamlining Drug Development: From Developability Assessment To High-Concentration Formulation Development6/19/2025
Explore a strategic approach to accelerating biologics formulation by gaining early insight into molecular properties and optimizing high-concentration conditions with minimal protein input.
DRUG DEVELOPMENT SOLUTIONS
-
![Natoli Tablet Presses- Feature]( "Pharmaceutical Tablet Presses")
Natoli’s line of affordable tablet presses is designed, engineered, and manufactured in the U.S.A. and built on our decades of experience in the tableting industry. We know our customers want presses that efficiently meet their R&D and/or production needs.
With Natoli you have a choice in your tablet press: R&D or production, single-station or rotary, fully automated or manual. Whatever your need, Natoli’s best-in-class tablet presses can help you optimize tablet quality while saving time and reducing costs.
-
![development of pharmaceutical products-GettyImages-1054374630]( "Solid State R&D And Pre-Formulation")
Guided by Quality by Design (QbD) principles, our experienced scientists develop tailored strategies that optimize product performance, manufacturability, stability, and regulatory readiness across all stages of development.
-
![Solutions For Injectables]( "Solutions For Injectables And Parenteral Formulations")
Sterility is key for high-risk applications such as injectables, parenteral formulations, ophthalmic and peritoneal dialysis solutions, and many more.
-
Enhance your research and obtain exceptional imaging and analysis with a configurable and upgradeable high-content screening system that captures high-definition images and robust data from 2D and 3D assays.
-
![I01_Labs 173_WestPharm_Direct 113018-143]( "Don't Just Launch Your Molecule, Protect It!")
Accelerate your path to market with integrated support to streamline processes, reduce delays, and deliver safe, user-friendly drug-delivery solutions.
